UA39355A - Method for estimating "dry mass" and optimal volume of ultrafiltration in patients subjected to programmed hemodialysis - Google Patents

Method for estimating "dry mass" and optimal volume of ultrafiltration in patients subjected to programmed hemodialysis

Info

Publication number
UA39355A
UA39355A UA2000053065A UA200053065A UA39355A UA 39355 A UA39355 A UA 39355A UA 2000053065 A UA2000053065 A UA 2000053065A UA 200053065 A UA200053065 A UA 200053065A UA 39355 A UA39355 A UA 39355A
Authority
UA
Ukraine
Prior art keywords
dry mass
ultrafiltration
estimating
hemodialysis
optimal volume
Prior art date
Application number
UA2000053065A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ігор Миколайович Родін
Игорь Николаевич Родин
Віктор Костянтинович Денисов
Виктор Константинович Денисов
Вадим Васильович Захаров
Вадим Васильевич Захаров
Original Assignee
Донецький Державний Медичний Університет
Донецкий государственный медицинский университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Донецький Державний Медичний Університет, Донецкий государственный медицинский университет filed Critical Донецький Державний Медичний Університет
Priority to UA2000053065A priority Critical patent/UA39355A/en
Publication of UA39355A publication Critical patent/UA39355A/en

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

The method for estimating "dry mass" and the optimal volume of ultrafiltration in the patients subjected to the programmed hemodialysis comprises the clinical examination of the patient. In addition, the thoracic rheography is performed prior to hemodialysis for precise estimation of the "dry mass". The invention relates to the medicine and the nephrology and may be useful for treating the patients with the terminal renal failure in the departments of the programmed hemodialysis.
UA2000053065A 2000-05-30 2000-05-30 Method for estimating "dry mass" and optimal volume of ultrafiltration in patients subjected to programmed hemodialysis UA39355A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2000053065A UA39355A (en) 2000-05-30 2000-05-30 Method for estimating "dry mass" and optimal volume of ultrafiltration in patients subjected to programmed hemodialysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2000053065A UA39355A (en) 2000-05-30 2000-05-30 Method for estimating "dry mass" and optimal volume of ultrafiltration in patients subjected to programmed hemodialysis

Publications (1)

Publication Number Publication Date
UA39355A true UA39355A (en) 2001-06-15

Family

ID=74208843

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000053065A UA39355A (en) 2000-05-30 2000-05-30 Method for estimating "dry mass" and optimal volume of ultrafiltration in patients subjected to programmed hemodialysis

Country Status (1)

Country Link
UA (1) UA39355A (en)

Similar Documents

Publication Publication Date Title
PL1641918T3 (en) Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
ATE417639T1 (en) DEVICE FOR DETERMINING DIALYSIS EFFICIENCY
ATE405277T1 (en) SUBSTITUTION INFUSION FLUID AND CITRATE ANTICOAGULATION
DE69728236D1 (en) Device for the non-invasive determination of the glucose concentration in the blood
IL149662A0 (en) Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
IL205242A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
DE60000544T2 (en) Method and device for determining the dry weight of a patient with renal failure
EP2497501A3 (en) Radionuclides for medical use
AU2003295325A8 (en) Heart bypass system incorporating minimized extracorporeal blood circulation system and related method of use
SE9600631D0 (en) Use of a solution containing glucose for peritonial dialysis having reduced formation of AGE products
BR9713653B1 (en) pharmaceutical composition, method for preparing a pharmaceutical composition, and use of ferric pyrophosphate.
Kelton et al. Comparison of chemical composition of peritoneal fluid and serum: a method for monitoring dialysis patients and a tool for assessing binding to serum proteins in vivo
UA39355A (en) Method for estimating "dry mass" and optimal volume of ultrafiltration in patients subjected to programmed hemodialysis
CA2458740A1 (en) Method of treating systemic inflammatory response syndrome
HUP0401188A2 (en) Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander
Rubin et al. A double blind trial of dipyridamole in CAPD
Hyver et al. An in vivo analysis of reverse ultrafiltration during high-flux and high-efficiency dialysis
WO1998052617A3 (en) Contrast media for imaging of lung draining lymph nodes, administered through the lungs
AU2001248355A1 (en) The use of anticoagulant agents in the extracorporeal treatment of blood
Gopaul et al. Peritonitis in a C. A. P. D. patient due to Micrococcus mucilaginosus.
IT1271732B (en) Polyamidoamine salts having heparin-absorbent properties in whole blood
Taraba et al. Dialysis treatment in multiple myeloma
Mishriki What's eating these red blood cells?
Funck‐Brentano The current status and future of the artificial kidney
Perilli et al. Pulmonary gas exchange during orthotopic liver transplantation